[1] LUTZ T A. Control of food intake and energy expenditure by amylin-therapeutic implications.[J]. International Journal of Obesity, 2009, 33 Suppl 1: S24-7. DOI:
10.1038/ijo.2009.13[2] NAMBI AIYAR. Differential Calcitonin Gene-Related Peptide (CGRP) and Amylin Binding Sites in Nucleus Accumbens and Lung: Potential Models for Studying CGRP/Amylin Receptor Subtypes[J]. Journal of Neurochemistry, 1995, 65 3: 1131-1138. DOI:
10.1046/j.1471-4159.1995.65031131.x[3] G J COOPER. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1987, 84 23: 8628-8632. DOI:
10.1073/pnas.84.23.8628[4] DAHABADA H J LOPES. Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP).[J]. The Journal of Biological Chemistry, 2004: 42803-42810. DOI:
10.1074/jbc.m406108200[5] PING CAO Daniel P R Andisheh Abedini. Aggregation of islet amyloid polypeptide: from physical chemistry to cell biology[J]. Current opinion in structural biology, 2013, 23 1: Pages 82-89. DOI:
10.1016/j.sbi.2012.11.003[6] A. ELAINE TOMLINSON David R P. Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens[J]. British Journal of Pharmacology, 1996, 117 6: 1362-1368. DOI:
10.1111/j.1476-5381.1996.tb16737.x